» Articles » PMID: 28880926

Determination of Medical Abortion Eligibility by Women and Community Health Volunteers in Nepal: A Toolkit Evaluation

Overview
Journal PLoS One
Date 2017 Sep 8
PMID 28880926
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine if pregnant, literate women and female community health volunteers (FCHVs) in Nepal can accurately determine a woman's eligibility for medical abortion (MA) using a toolkit, compared to comprehensive abortion care (CAC) trained providers.

Study Design: We conducted a prospective diagnostic accuracy study in which women presenting for first trimester abortion, and FCHVs, independently assessed each woman's eligibility for MA using a modified gestational dating wheel to determine gestational age and a nine-point checklist of MA contraindications or cautions. Ability to determine MA eligibility was compared to experienced CAC-providers using Nepali standard of care.

Results: Both women (n = 3131) and FCHVs (n = 165) accurately interpreted the wheel 96% of the time, and the eligibility checklist 72% and 95% of the time, respectively. Of the 649 women who reported potential contraindications or cautions on the checklist, 88% misidentified as eligible. Positive predictive value (PPV) of women's assessment of eligibility based on gestational age was 93% (95% CI 92, 94) compared to CAC-providers' (n = 47); PPV of the medical contraindications checklist and overall (90% [95% CI 88, 91] and 93% [95% CI 92, 94] respectively) must be interpreted with caution given women's difficulty using the checklist. PPV of FCHVs' determinations were 93% (95% CI 92, 94), 90% (95% CI 89,91), and 93% (95% CI 91, 94) respectively.

Conclusion: Although a promising strategy to assist women and FCHVs to assess MA eligibility, further refinement of the eligibility tools, particularly the checklist, is needed before their widespread use.

Citing Articles

Medical abortion in Nepal: a qualitative study on women's experiences at safe abortion services and pharmacies.

Rogers C, Sapkota S, Paudel R, Dantas J Reprod Health. 2019; 16(1):105.

PMID: 31307474 PMC: 6632190. DOI: 10.1186/s12978-019-0755-0.


Gestational dating using last menstrual period and bimanual exam for medication abortion in pharmacies and health centers in Nepal.

Averbach S, Puri M, Blum M, Rocca C Contraception. 2018; 98(4):296-300.

PMID: 29936150 PMC: 6139283. DOI: 10.1016/j.contraception.2018.06.004.


Determination of medical abortion success by women and community health volunteers in Nepal using a symptom checklist.

Andersen K, Fjerstad M, Basnett I, Neupane S, Acre V, Sharma S BMC Pregnancy Childbirth. 2018; 18(1):161.

PMID: 29751788 PMC: 5948871. DOI: 10.1186/s12884-018-1804-3.


A research agenda for moving early medical pregnancy termination over the counter.

Kapp N, Grossman D, Jackson E, Castleman L, Brahmi D BJOG. 2017; 124(11):1646-1652.

PMID: 28317327 PMC: 5637897. DOI: 10.1111/1471-0528.14646.

References
1.
Puri M, Tamang A, Shrestha P, Joshi D . The role of auxiliary nurse-midwives and community health volunteers in expanding access to medical abortion in rural Nepal. Reprod Health Matters. 2015; 22(44 Suppl 1):94-103. DOI: 10.1016/S0968-8080(14)43784-4. View

2.
Samandari G, Wolf M, Basnett I, Hyman A, Andersen K . Implementation of legal abortion in Nepal: a model for rapid scale-up of high-quality care. Reprod Health. 2012; 9:7. PMC: 3373381. DOI: 10.1186/1742-4755-9-7. View

3.
. The efficacy and tolerance of mifepristone and prostaglandin in first trimester termination of pregnancy. UK Multicentre Trial. Br J Obstet Gynaecol. 1990; 97(6):480-6. DOI: 10.1111/j.1471-0528.1990.tb02516.x. View

4.
Tang O, Chan C, Ng E, Lee S, Ho P . A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation. Hum Reprod. 2003; 18(11):2315-8. DOI: 10.1093/humrep/deg475. View

5.
Ashok P, Penney G, Flett G, Templeton A . An effective regimen for early medical abortion: a report of 2000 consecutive cases. Hum Reprod. 1998; 13(1O):2962-5. DOI: 10.1093/humrep/13.10.2962. View